Chinguetti
I thought you were into HDR and HDRO pretty seriously from your posts during last year's action. It's been a long wait since then - hopefully we will see days of > 20m shares trading per day again !! (and a rising price).
I too have devoted enormous amounts of time to researching HDR last year and since. That's why I kept buying more (HDRO's unfortunately) - it's a great story.
With all the focus on the current well and the market's response to its success or otherwise, it is easy to lose sight of the big picture - which is what attracted me to HDR in the first place. This time around there is much more happening in the near-term after Chinguetti 4-2. There's Banda (very exciting) and the the third well in Area C which HDR regards as low risk. And then there's the Block 7 JV area with Dana and WPL (drilling early 2003). And of course a possible takeover by WPL (particularly if someone else makes a move). All this makes it far easier to justify holding on tight even if Chinguetti 4-2 disappoints in some way.
There's heaps more of course - all the other prospects iin blocks 2-6 for instance. Then there's the new 3D seismic that so far has brought Banda into the current drilling program - we are in the dark as usual as to what else it showed. Then there's block 2, and down the track - the other project areas.
This has been the longest and toughest investment that I've made and I think that the story will be going on for some time to come.
I'd enjoy getting together with you and other HDR officianados - win, lose or draw.
Cheers
H
- Forums
- ASX - By Stock
- HDR
- BANDA reserve estimates
HDR
hardman resources limited
BANDA reserve estimates, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online